Viking Therapeutics Inc (VKTX) reports significant progress in clinical trials and maintains a strong cash position despite increased R&D and administrative costs..
Sports
Viking Therapeutics Inc (VKTX) Q1 2025 Earnings Call Highlights: Strategic Advances Amid Rising ...
Viking Therapeutics Inc (VKTX) reports significant progress in clinical trials and maintains a strong cash position despite increased R&D and administrative costs.